← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 1997Last known activity
Dec 31, 2025
Timeline
1980s
- Oct 1, 1985
HOVON - Dutch Haemato-Oncology Association— Founded
Drugs by trial phase (63 distinct, 46 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (37 own, 0 via acquisition)
Indications
Studied for
- Anemia, Refractory, with Excess of Blasts
- Infections
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, Promyelocytic, Acute
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Multiple Myeloma
- Myelodysplastic Syndromes
- Neoplasms, Plasma Cell
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Primary Myelofibrosis
- Smoldering Multiple Myeloma
- Syndrome
Recent trials (48)
- NCT07223814Lead sponsorPhase 3Dec 31, 2025
- NCT07107529CollaboratorPhase 2Oct 31, 2025
- NCT07075016Lead sponsorPhase 3Aug 5, 2025
- NCT06652438Lead sponsorPhase 3Feb 13, 2025
- NCT06605586Lead sponsorPhase 1/Phase 2Oct 15, 2024
- NCT06220032Lead sponsorPhase 3Aug 15, 2024
- NCT06187441Lead sponsorPhase 3May 14, 2024
- NCT06067048Lead sponsorPhase 2Feb 1, 2024
- NCT06014489Lead sponsorPhase 2Dec 31, 2023
- NCT05791409Lead sponsorPhase 1/Phase 2Nov 9, 2023
- NCT05502250Lead sponsorPhase 2Apr 30, 2023
- NCT05641428CollaboratorPhase 2Oct 18, 2022
- NCT05063123Lead sponsorPhase 2Jan 31, 2022
- NCT04628026CollaboratorPhase 3Oct 30, 2021
- NCT04876716CollaboratorPhase 3May 11, 2021
Details
- Founded
- Amsterdam, NL Oct 1, 1985
- Last known activity
- Dec 31, 2025